Lataa...
Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma
<p>Abstract</p> <p>Background</p> <p>Despite all benefit provided by established therapies prognosis of gastric cancer remains poor. Targeted inhibition of platelet derived growth factor receptor (PDGFR) by imatinib may influence tumor growth and amplify chemotherapeuti...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2012-12-01
|
| Sarja: | BMC Cancer |
| Aiheet: | |
| Linkit: | http://www.biomedcentral.com/1471-2407/12/587 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|